feature photo

Publications

 

Click links below to jump to section

8th International Workshop of HIV Pediatrics

TB 2016

AIDS 2016

 

8th International Workshop of HIV Pediatrics, 15-16 July 2016

Protocol Title Authors Presentation Type, Time
Friday, 15 July 2016


P1110


Raltegravir (RAL) Pharmacokinetics (PK) and Safety in HIV-1 Exposed Neonates at High Risk of Infection (IMPAACT P1110)


Clarke DF, Acosta EP, Chain A, Cababasay M, Wang J, Calabrese K, Spector SA, Bryson YJ, Teppler H, Popson S, Graham B, Smith B, Hazra R, Homony B, Murray R, and Mirochnick M and the P1110 Protocol Team


Oral presentation,
12:15 am

Saturday, 16 July 2016


PROMISE 1077BF


Comparing Maternal Triple Antiretrovirals (mART) and Infant Nevirapine (iNVP) Prophylaxis for the Prevention of Mother-to-Child Transmission (MTCT) of HIV during Breastfeeding (BF)


Taha T, Flynn P, Cababasay M, Fowler MG, Mofenson L, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanshanmugam D, Chakhtoura N, McCarthy K, Kawalazira R, Mukuzunga C, Moodley D, and the PROMISE Study Team


Oral presentation,
11:15 am


PROMISE P1084s


Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa


Stranix-Chibanda L, Tierney C, Marr C, George K, Sebikari D, Dadabhai S, Zanga A, Mukwasi C, Vhembo T, Fan B, Browning R, Mofenson L, Shepherd J, Fowler MG, Siberry G


Oral presentation,
11:45 am


P1104s


Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial is poorer than non-infected children at those study sites


Boivin M, Chernoff M, Zimmer B, Laughton B, Joyce C, McCarthy K, Brouwers P, Jean-Philippe P, Lee S, Coetzee J, Violari A, Cotton M, Palumbo P, and the P1104s Study Team


Oral presentation,
2:30 pm


PROMISE 1077BF, 1077FF, 1077HS


Low acceptance of early antiretrovial therapy (ART) among post-partum women in 14 countries across the globe


Stranix-Chibanda L, Brummel S, Coletti A, Pilotto J, Nematadzira T, Kamateeka M, Masheto G, Chamanga R, Maluwa M, Hanley S, Browning R, Chakhtoura N, Basar M, Currier J, Fowler MG


Poster


PROMISE 1077BF, P1084s


Impact of maternal triple antiretroviral therapy (ART) versus infant nevirapine prophylaxis on somatic growth of breastfeeding infants in the PROMISE trial


Stranix-Chibanda L, Tierney C, Marr C, George K, Musoke P, Chipoka G, Mallewa M, NaidAoo M, Nematadzira T, Kusakara B, Violari A, Mbengeranwa T, Browning R, Fowler MG, Siberry G, PROMISE 1077BF Study Team


Poster


P1025


Pregnancy and Birth Outcomes of Perinatally HIV-infected Women in the U.S.: A Combined Analysis of the PHACS SMARTT study and IMPAACT P1025 Protocol


Jao J, Kacanek D, Williams P, Geffner M, Livingston E, Sperling R, Patel K, Bardeguez A, Burchett S, Chakhtoura N, Scott G, Van Dyke R, and Abrams EJ for the Pediatric HIV/AIDS Cohort Study (PHACS) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1025 Protocol


Poster


PROMISE


Neurodevelopment of Ugandan and Malawian PROMISE HIV unexposed uninfected children at 12 and 24 months of age


Boivin MJ, Maliwichi-Senganimalunje L, Nyakato M, Sikorskii A, Wambuzi Ogwang A, Kawalazira R, Mallewa M, Familiar-Lopez I, Ruiseñor-Escudero H, Aizire J, Taha T, Fowler MG


Poster


PROMISE


Growth at 12 and 24 months-of-age among PROMISE (HIV and ARV) exposed uninfected versus unexposed children in Malawi and Uganda


Aizire J, Sikorskii A, Wambuzi Ogwang L, Mallewa M, Familiar-Lopez I, Mutebe A, Dadabhai S, Taha T, Boivin MJ, Fowler MG for the PROMISE Neurodev Study Team


Poster

 

TB 2016, 16-17 July 2016

Protocol Title Authors Presentation Type, Time
Sunday, 17 July 2016


P1113


IMPAACT P1113/Aeras C-015-404: Phase I/II Study of H4:IC31 in BCG-Primed Infants


Nachman S, Andersen-Nissen E, Fiore-Gartland A, Hural J, McElrath MJ, Shi S, Eisner J, Coletti A, Dintwe O, DiazGranados D, Jean-Philippe P, Cotton M, Fairlie L, Violari A, and the P1113 study team


Poster


PHOENIx 2003


A5300/I2003: Feasibility of identifying, recruiting, and characterizing adult MDR TB index cases and their adult and child household contacts on four continents


Swindells S, Kim S, Gupta A, Hesseling A, Shah S, Johnson D, Harrington M, Suryavanshi N, Sanchez J, Dawson R, Naini L, Jones L, Hughes M, Churchyard G


Poster

 

21st International AIDS Conference, 18-22 July 2016

Protocol Title Authors Presentation Type, Time
Tuesday, 19 July 2016


PROMISE 1077BF


Comparing Maternal Triple Antiretrovirals (mART) and Infant Nevirapine (iNVP) Prophylaxis for the Prevention of Mother-to-Child Transmission (MTCT) of HIV during Breastfeeding (BF)


Taha T, Flynn P, Cababasay M, Fowler MG, Mofenson L, Owor M, Shapiro D, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanshanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Kawalazira R, Moodley D, Nematadzira T, Kusakara B, Bhosale R, Vhembo T, Bobat R, Mmaga B, Masenya M, Nyati M, Theron G, Mulenga HB, PROMISE Study Team


Poster


P1104s


Neuropsychological performance of HIV-infected and uninfected African children


Boivin M, Chernoff M, Laughton B, McCarthy K, Barlow-Mosha L, Brouwers P, Jean-Philippe P, Violari A, Cotton M, Palumbo P, and the P1104s Study Team


Poster

Wednesday, 20 July 2016


P1025


Pregnancy and Birth Outcomes of Perinatally HIV-infected Women in the U.S.: A Combined Analysis of the PHACS SMARTT study and IMPAACT P1025 Protocol


Jao J, Kacanek D, Williams P, Geffner M, Livingston E, Sperling R, Patel K, Bardeguez A, Burchett S, Chakhtoura N, Scott G, Van Dyke R, Abrams EJ, for the Pediatric HIV/AIDS Cohort Study (PHACS) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1025 Protocol


Oral presentation,
11:00 am – 12:30 pm


P1115


Establishing a Treatment Dose of Nevirapine (NVP) for Full-term Neonates with Perinatal HIV Infection: IMPAACT P1115


Chadwick EG, Qin M, Bryson Y, Mirochnick M, Ruel T, Zadzilka A, Coletti A, Zimmer B, Tierney C, Persaud D Cotton M, Jean-Philippe P, Hazra R, Jennings C and Capparelli EV for the IMPAACT P1115 Team


Poster

Thursday, 21 July 2016


PROMISE 1077HS


Randomized Trial of Stopping or Continuing ART among Postpartum Women with Pre-ART CD4 > 400 cells/mm3 (IMPAACT PROMISE 1077HS)


Currier J, Britto P, Hoffman R, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Chakhtoura N, Browning N, Coletti A, Shapiro D, Pilotto J, PROMISE 1077HS Team


Oral presentation,
11:00 am – 12:30 pm


PROMISE 1077BF, 1077FF, 1077HS


Low acceptance of early antiretroviral therapy (ART) among post-partum women enrolled in the IMPAACT PROMISE studies across the globe


Stranix-Chibanda L, Brummel S, Angelidou K, Tierney C, Coletti A, McCarthy K, Pilotto J, Mutambanengwe M, Chanaiwa V, Mhembere T, Kamateeka M, Masheto G, Chamanga R, Maluwa M, Hanley S, Joao E, Theron G, Chandawale A, Nyathi M, Santos B, Aurpibul L, Mubiana-Mbewe M, Oliveira R, Basar M, Chakhtoura N, Browning R, Currier J, Fowler MG, PROMISE study team


Oral presentation,
11:00 am – 12:30 pm


PROMISE


Neurodevelopment of Ugandan and Malawian PROMISE HIV unexposed uninfected children


Boivin MJ, Sikorskii A, Aizire J, Maliwichi- Senganimalunje L, Wambuzi Ogwang L, Nyakato M, Mallewa M, Familiar-Lopez I, Ruiseñor-Escudero H, Taha T, Fowler MG


Oral poster discussion,
1:00 pm – 2:00 pm

 

← Publications Home

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.